Article
Impact of ABCB1 variants on neutrophil depression: a pharmacogenomic study of paclitaxel in 92 women with ovarian cancer.
Basic & clinical pharmacology & toxicology - 1 Feb 2012
Bergmann Troels K, Brasch-Andersen Charlotte, Gréen Henrik, Mirza Mansoor R, Skougaard Kristin, Wihl Jessica, Keldsen Nina, Damkier Per, Peterson Curt, Vach Werner, Brøsen Kim
Abstract excerpt
The standard treatment for ovarian cancer in advanced stages is post-surgery treatment with taxane-platin chemotherapy. Despite an initial high response rate, most patients eventually relapse. The dose-limiting toxicities of paclitaxel are neutropenia and neuropathy, but the inter-individual variability is large. The aim of this prospective study was to investigate the impact of genetic variants in key drug...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
